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SURGERY FOR “DOUBLE JEOPARDY” IN THE LUNG: LUNG CANCER AND MULTIPLE LUNG 
METASTASES OF PAPILLARY CARCINOMA OF THE THYROID
Yukihito Saito, MD,a Hideyasu Omiya, MD,a Yuzo Shomura, MD,a Hiroji Imamura, MD,a and Akiharu Okamura, MD,a
Osaka, Japan
We have performed surgery on several patients with primary
lung cancer and a synchronous/metachronous cancer of anoth-
er organ. However, we have never before treated a patient with
primary lung cancer and multiple synchronous metastases
from thyroid cancer in both lungs. Although patients with pap-
illary thyroid carcinoma have a favorable long-term prognosis,
the subgroup who have distant metastases are known to have
a worse prognosis.1 It is difficult to plan the treatment of
patients in such a “double jeopardy” situation.
We describe our first experience treating a patient with
double jeopardy in the lung: primary lung cancer and multi-
ple lung metastases of papillary carcinoma of the thyroid.
Clinical summary. A 68-year-old woman had a mass on a
follow-up chest x-ray film after surgery for thyroid papillary
carcinoma. Bilateral miliary nodular lesions were observed
on chest computed tomography at the time of admission. The
patient had undergone total thyroidectomy for papillary car-
cinoma of the thyroid 5 years earlier. A biopsy specimen at
bronchoscopy revealed a poorly differentiated adenocarcino-
ma of the lung. However, we could not determine whether the
bilateral multiple small nodules were metastases from the
lung cancer or the thyroid carcinoma. If the miliary micro-
nodules were thyroid carcinoma metastases, the clinical TNM
stage of lung cancer would be T2 N0 M0.
We knew that patients with lung metastases from thyroid
carcinoma have a relatively good prognosis, with an estimat-
ed mean survival of 77% at 8 years. Therefore this patient’s
life-limiting factor was the lung cancer, not the thyroid carci-
noma metastases. We recommended that she undergo surgery
for lung cancer. However, because she had no symptoms, she
refused both the operation and anticancer chemotherapy.
Seven months later, she decided to undergo surgery because
she had bloody sputum. If the micronodules were metastases
from adenocarcinoma of the lung, the disease would be too
advanced for lung resection. Therefore some micronodules
were sampled by open lung biopsy through a minithoracoto-
my approach at the time of operation. Pathologic examination
showed that these micronodules were metastases from papil-
lary carcinoma of the thyroid. Mediastinal lymph nodes were
also sampled through the minithoracotomy and were negative
for malignancy. No pleural dissemination was observed. We
therefore decided to perform a right upper lobectomy.
A lung cancer measuring 34 · 24 mm was located at S2 of
the right lung. We completed the right upper lobectomy.
Pathologic TNM staging was stage II. Pathologic examina-
tion of the resected specimens demonstrated a marked con-
trast in the growth characteristics of the 2 tumors. In the lung
cancer, Ki-67 antigen expression was observed in many
tumor cells. By flow cytometric cell cycle analysis, the DNA
histogram was aneuploid and the S+G2+M phase fraction
was 52%. In contrast, the lung metastases from the papillary
From the Department of Thoracic and Cardiovascular Surgery,a
Division of Surgical Pathology,b Kansai Medical University,
Moriguchi, Japan.
Received for publication April 27, 1999; accepted for publication
June 3, 1999.
Address for reprints: Yukihito Saito, MD, 10-15 Fumizonocho,
Moriguchi, Osaka 570-8507, Japan.
J Thorac Cardiovasc Surg 1999;118:747-8
Copyright © 1999 by Mosby, Inc.
0022-5223/99 $8.00 + 0 12/54/100613
748 Brief communications The Journal of Thoracic and
Cardiovascular Surgery
October 1999
thyroid carcinoma had an extremely low level of Ki-67 anti-
gen expression, a diploid DNA histogram, and a small growth
fraction (Fig 1).
Comment. Lobectomy for primary lung cancer with coex-
isting metastases in the same lung has to our knowledge never
been reported in the literature. Although papillary thyroid car-
cinoma is associated with a favorable long-term survival, the
presence of metastases in distant sites other than the lung,
such as bone, brain, and liver, is an important unfavorable
prognostic indicator.2 The mortality rate rises after age 70 and
falls before age 40 years. However, even without specific
treatment, pulmonary metastases may follow a very slow
course. The miliary variety of pulmonary metastases para-
doxically carries a favorable prognosis. In our patient, Ki-67
antigen expression and growth fraction in the micronodular
pulmonary metastases was extremely low, in contrast to the
lung cancer. Micronodular metastases occur more frequently
in papillary thyroid carcinoma than in follicular thyroid car-
cinoma. The prognosis of micronodular metastases is favor-
able, with a 77% likelihood of survival at 8 years.3 Our
patient was 68 years old and had micronodular metastasis
from papillary carcinoma. We recommended that she under-
go surgery for her lung cancer. However, she refused surgical
treatment as well as anticancer chemotherapy, and the lung
cancer doubled in size in 7 months after the diagnosis. The
actuarial 2-year survival of advanced non–small cell lung
cancer is 7.4% even in patients who receive platinum-based
anticancer chemotherapy.4 We again recommended surgery,
and she finally agreed to undergo the lung operation. Three
years after the operation, she is free of symptoms and enjoys
a good quality of life. To date, chest computed tomography
reveals no recurrence of the lung cancer and no progression
of the remaining micronodular thyroid carcinoma metastases.
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Fig 1. Histologic findings: Ki-67 antigen expression was observed in many tumor cells in the lung cancer region
(asterisk). In contrast, the lung metastases from the papillary thyroid carcinoma (arrow) had an extremely low
level of Ki-67 antigen expression.
